Establishment of Long-Term Agreements (LTAs) for the Supply of Laboratory Equipment, In Vitro Diagnostic (IVD) Equipment, Biosafety Equipment, and Laboratory Furniture for UN WebBuy Plus

New clarification added: Question : Regarding Item 30 – Start-up Reagent Package: The chemistry analyzer supports a broad range of panel/tests, each requiring specific reagents. Since testing requirements vary among countries and end users, it is not possible to provide a standard start-up reagent package applicable to all cases. We would therefore suggest that the start-up reagent package be finalized and quoted separately once the beneficiary/end user has confirmed the required test menu and reagent requirements Answers : clarifies that the specification does not require bidders to provide assay-specific reagents or a predefined test menu as part of the start-up package.The requirement is limited to the provision of general system consumables necessary for installation, commissioning, calibration, quality control, verification, and routine operation of the offered analyzer. As stated in the specification. The start-up package shall include, at a minimum, quality control materials, calibrators, cuvettes (where applicable), cuvette and probe wash solutions, sample cups or sample tubes (where applicable), and any other non-assay-specific consumables required for analyzer operation. Accordingly, bidders shall estimate and include sufficient quantities of such consumables, taking into account the offered technology, system configuration, calibration requirements, quality control procedures, and repeat testing, to support a minimum of 500 tests.

New clarification added: Question:  if we have after-sales services/dealers in a few African or other continental countries ,would our offer be accepted for supply to those countries?Answer: The availability of an after-sales service network in Africa, Asia & Middle East, and the Americas will be assessed against the applicable after-sales service requirements in Annex 4 – Worldwide Commercialization Capability

New clarification added: Question: "If required, the SUPPLIER shall affix to the equipment a label indicating the serial number and the identification of the corresponding project, in accordance with the UNOPS design or as required by the purchasing institution.” Could you please clarify whether the label/sticker will be provided by UNOPS or the purchasing institution? If not, should the cost of designing and producing the label/sticker be included in our quotation?Answer : UNOPS or the purchasing institution will provide the design and content of the label/sticker, if required. The supplier shall be responsible for printing the label/sticker and affixing it to the equipment. Any associated costs should be included in the quoted price.

New clarification added: Question: Could you advise about the destination to let us know about the shipping costAnswer: Prices were requested on an FCA basis. Therefore, bidders are not required to include international shipping costs to a specific destination in their bid submission.Question: Regarding Item 20, No. 50 under the Mandatory Options, is the trolley intended for transporting the autoclave? If so, are there any specific requirements regarding the trolley's dimensions, material, or design?Answer: The trolley listed under Item 20, No. 50 in the Mandatory Options is not intended for transporting the autoclave itself. It refers to the loading trolley used for safely transferring materials into and out of the autoclave chamber. It should be recommended by the manufacturer for compatibility with the offered autoclave model and must be suitable for the chamber size,

New clarification added: Question: We are preparing our bid for the tenders referenced in the parameter response files. While we are able to comply with the vast majority of the technical requirements, we have identified a small number of parameters that our offered equipment cannot fully meet.Could you please advise whether UNOPS would still consider a bid that contains a few non-compliant technical specifications? If yes, what is the maximum number or percentage of non-compliant points of each item permitted for a bid to remain eligible for award? Thank you for your clarification. Is it mandatory to be 100% compliant with the tender specifications in order to submit a bid?Answer: UNOPS does not establish a predefined maximum number or percentage of non-compliant technical specifications that would automatically remain eligible for award.As this is an ITB, bids are evaluated on a pass/fail basis to determine substantial compliance with the requirements of the solicitation.

New clarification added: Question:  Item 20/21/22 Vertical Steam Sterilizer: MD/MDR Certification is mandatory? Do you recognize some manufacturer having obtained MD/MDR Certification for Vertical Steam Sterilizer? This device is intended for use in research institute and university laboratories, third-party testing laboratories, and biological R&D laboratories; it handles loadings such as laboratory glassware, plastic consumables, microbial media, experimental bacterial samples, experimental solid waste, and non-medical laboratory instruments. Generally, it is not used for sterilizing medical diagnostics or puncturing devices for patients and not categorized as sterilization equipment serving human medical diagnostics under MDR regulations.Answer: The classification of a steam sterilizer is determined by its intended use as specified by the manufacturer and not by the orientation of the chamber (vertical or horizontal)The vertical steam sterilizers specified under Items 20, 21 and 22 are intended for medical/healthcare use and for sterilization of reusable medical instruments and related healthcare materials. Therefore, compliance with applicable medical device regulatory requirements , is considered appropriate and remains a mandatory requirement.. 

New clarification added: Question: Could you please kindly extend the submission deadline by two weeks?Answer: The bid closing deadline was extended to 13 July 2026 at 10:00 UTCQuestion: As there are 43 different items/lots in the tender, please confirm whether bidders are required to quote for all items/lots or whether we may submit quotations only for the item(s)/lot(s) of our interest and capability.Answer: Bidders are not required to submit quotations for all items. Bidders may submit quotations for one or more items based on their interest and capability. The evaluation will be conducted on a per-item basis. 

New amendment added #2: Revision of the Deadline date and  Clarifications. The relevant Contract provisions indicated below are amended to read as follows;Deadline under General2026-07-13 10:00 UTC Clarifications under General2026-06-24 10:00 UTC

New clarification added: Question :  we would like to participate in yours tender ITB/2026/62934. howevr, since the tender covers multiple destination country of beneficiary countries, I would like to know whether i can participate for Pakistan only.Answer: This is an open international tender. Bids cannot be restricted to a specific beneficiary country. Any resulting LTA is intended for global use and bidders shall meet the worldwide commercialization capability requirements in Annex 4.

New clarification added: Subject: Request for Clarification – ITB/2026/62934 –Clinical Chemistry Analyzer (Item 30) and Hematology Analyzer (Item 31)  We are preparing our bid for the above-referenced tender and would like to request clarification on several technical requirements forItem 30 – Automated clinical chemistry analyzer, and  Item 31 – Hematology analyzer, 5-parts differentialbased on the specification compliance sheets we have reviewed. The points of uncertainty are listed below. We would greatly appreciate your guidance on whether the current requirements are mandatory as written, or if alternative interpretations / technical solutions may be accepted. A. Item 30 – Automated Clinical Chemistry AnalyzerQuestion:  1.A.4 / 1.D.20Open platform with no restrictions on reagent bottle shape or volumeOur analyzer is open for third‑party reagents, but due to mechanical probe and liquid level sensing limitations, it cannot accept every bottle shape/volume. It is compatible with most universal 20‑70 mL bottles. Is this acceptable, or do you require absolute unrestricted compatibility?Answer: An analyzer compatible with mainstream universal reagent formats (e.g., 20–70 mL bottles commonly used by reagent suppliers) will be considered acceptable.Question: 1.E.25User‑programmable incubation cycles managed per assay (not locked to proprietary kits)We did not find an explicit description in the manual. The software does allow user‑defined parameters and timing for assays. Could you clarify what specific “incubation cycles” need to be programmable?Answer: Incubation cycles” refers to the programmable incubation steps within an assay method (e.g., incubation time, temperature, mixing sequence) that the analyzer must allow users to define and manage independently. The requirement is that these cycles are not locked to proprietary reagent kits, but can be user‑programmed per assayQuestion: 1.G.33Detection of clots, bubbles, and insufficient volume in samples or reagentsOur analyzer detects liquid level, bubbles, and insufficient volume, but it does not detect blood clots. Is clot detection a mandatory requirement?Answer: The intent of this requirement is to ensure reliable sample and reagent aspiration and to minimize analytical errors arising from clots, bubbles, or insufficient volume. Analyzers that provide equivalent protection through aspiration monitoring, pressure sensing, or other validated mechanisms will be considered compliantQuestion: 1.G.36Automatic system self‑tests on startup, with menu‑driven troubleshooting and maintenance routinesWe have menu‑driven troubleshooting and maintenance functions, but “self‑test on startup” is not explicitly described in the user manual. Would you consider the existing maintenance and diagnostic routines as sufficient compliance?Answer: No. Menu-driven troubleshooting and maintenance functions alone will not be considered equivalent to automatic startup self-tests. The offered analyzer shall perform automatic system self-checks during startup/initialization.Question: 1.G.37Separate, dedicated probes for sample and reagent handlingOur analyzer uses a single probe for both sample and reagent, with thorough automatic rinsing between each dispensing to minimize carryover (carryover ≤0.1%). Is a physically separate probe mandatory, or can low carryover with a washed common probe be accepted?Answer: No, the specification requires separate, dedicated probes for sample and reagent handling to minimize cross‑contamination. Question: 1.H.43Automated instrument calibration functionalityThe instrument supports automatic calibration when programmed. Please confirm whether this meets your expectation of “automated calibration”.Answer: “instrument calibration” refers to the analyzer’s ability to automatically perform and manage test/method calibrations using calibrator materials, with software support for curve generation, factor application, and validity checks. It does not mean hardware calibration of the instrument itself.  B. Item 31 – Hematology Analyzer (5‑part differential)Requirement No.Requirement Summary Our Observation / QuestionQuestion: 1.D.163‑reagent system (diluent, lyse, cleaner)Our 5‑part analyzer uses a 4‑reagent system to achieve optimal 5‑part differential. In the market, 3‑reagent systems are typically used for 3‑part differential. May we offer a 4‑reagent system? Or is the requirement strictly limited to 3 reagents?Answer: Yes, for 5‑part hematology analyzers the requirement should be understood as diluent, two types of lysing solution (Lyse 1 and Lyse 2), and cleaner. Such systems are considered compliant.Question: 1.D.17Continuous loading/unloading of reagents during operation without interrupting analysisThis feature is commonly not available on any hematology analyzer, as reagent replacement requires brief interruption. It is generally found only on large biochemistry or immunoassay systems. Is this requirement absolutely mandatory for the hematology analyzer?Answer: The requirement refers to the analyzer’s ability to allow reagent bottles to be added or replaced during ongoing operation, without cancelling or interrupting tests already in progress.Question: 1.E.21Linearity ranges: RBC 0‑8.5×10¹²/L, HGB 0‑≥250 g/L, HCT 10‑60% Our offered model meets RBC 0‑8.00×10¹²/L and HGB 0‑240 g/L. HCT linearity is not a standard factory release or registration requirement in many regulatory frameworks. Would you consider accepting the values we have proposed as technically compliant?Answer: The specified linearity ranges are minimum performance requirements established to ensure adequate analytical performance across the expected clinical measuring range. Compliance shall be assessed against the values stated in the specification.Question: 1.F.26Automatic sample detection, including sample volumeNo hematology analyzer on the market can automatically detect the exact sample volume; only presence of a sample tube can be detected. May this requirement be waived or interpreted as “sample tube presence detection”?Answer: The requirement does not refer to measurement of the exact blood volume contained in the sample tube. The intent is that the analyzer shall automatically detect the presence of a sample and provide detection of insufficient sample volume,   

New clarification added: Question: Could you please advise whether you have any information regarding the regions, countries, or continents that are likely to be included under the Long-Term Agreement (LTA)? If this information is available, we would appreciate it if you could share the names of the countries expected to be covered.Answer: The countries of use under the resulting LTA cannot be confirmed in advance. However, bidders shall meet the technical requirements for worldwide commercialization capability. The offered Goods shall be supported by an after-sales service network in Africa, Asia & Middle East, and the Americas, with authorised service providers in at least three (3) countries per region, as detailed in Annex 4.

New clarification added: Item  31 Hematology analyzer, 5-parts differential1.A. General requirements. 5. “The analyzer shall be an open or semi open plaltform for the use of compatible reagents : - The system shall be compatible with one or more  third-party brands of validated reagents (lyse/diluent/cleaner), quality control materials, and calibrators.- The supplier must provide the device configured ready to use third party kits and reagents.- There must be no software, hardware or licence restrictions on the use of compatible and validated third-party reagents, and software updates must not restrict this either”.Question: Modern hematology analyzers are closed systems that work exclusively with the manufacturer's reagents. How to confirm the validity of third-party reagents if any manual for the device clearly states that the customer should work with the origin reagents? And it is indicated that the guarantee of accurate test results depends on working with origin reagents. Manufacturers of hematology instruments do not validate third-party reagents in any way.Answer: The requirement for “open or semi‑open platform” means that the analyzer must allow the use of at least one or more compatible third‑party reagents (e.g., diluent, cleaner), QC materials, and calibrators, without software, hardware, or licence restrictions. Absolute unrestricted third‑party reagent use is not expected, but semi‑open compatibility is required. Bidders should confirm which reagents are open/compatible in their offered analyzer and provide documentation proof.1.D. Reagents. 16. “3- reagents system: diluent, lyse, cleaner”. Question: 5 diff hematology analyzers use 2 types of lysing solution for complete cell differentiation. The requirement in this paragraph should be understood as meaning that the analyzer uses Diluent, Lysing solution of 2 types: lyse 1 and lyse 2, and Cleaner? Because clearly 3 reagents are used exclusively with 3-diff analyzers, where only one type of lysing solution is required.Answer: Yes, for 5‑part hematology analyzers the requirement should be understood as diluent, two types of lysing solution (Lyse 1 and Lyse 2), and cleaner. Such systems are considered compliant.Question: 17. “Enables continuous loading and unloading of reagents during operation without interrupting analysis”. How should this point be understood? That the analyzer automatically takes all the reagents necessary for measurement during the analysis and after the analysis drains them into the drain tank? Is it about replacing the reagents when they are finished, or when their shelf life expires? In the latter case, the procedure for loading and unloading reagents cannot be performed at the time of the operation and without interrupting the analysis.Answer: The requirement refers to the analyzer’s ability to allow reagent bottles to be added or replaced during ongoing operation, without cancelling or interrupting tests already in progress.Question: 1.F. Safety features. 26. “Automatic sample detection, including sample volume”. Question: Will a hematology analyzer that has automatic sample detection but no volume measurement be considered?Answer: The requirement does not refer to measurement of the exact blood volume contained in the sample tube. The intent is that the analyzer shall automatically detect the presence of a sample and provide detection of insufficient sample volume,Question: 32. “Calibration stability of minimium 30 days”. Question: How to confirm compliance with this requirement? Manufacturers of all hematology analyzers calibrate the instrument at the factory and recommend performing the next calibration after servicing the instrument. The calibration stability is not used for hematology analyzers.Answer: The intent of this requirement is to ensure stable calibration performance during routine operation without frequent recalibration. Compliance may be demonstrated through manufacturer's documentation indicating calibration retention, calibration stability, factory calibration validity, or recommended recalibration intervals under normal operating conditions.Question: 1.J. Standard accessories and consumables. 45. «Products with an expiration date shall have no less than 2/3 of their shelf life at the time of delivery».Question: Will it be enough to confirm this requirement with a warranty letter from the official distributor?Answer: The requirement refers to the remaining shelf life of products at the time of delivery. Compliance shall be determined based on the product manufacturing date, expiry date, and delivery date. A warranty/undertaking letter from the bidder or authorized distributor may be submitted as confirmation at the bidding stage; however, compliance shall be verified upon delivery.

New clarification added: Question: It's noticed that the sterilizers are classified as MD.We have started the EU MDR application 1 year ago, but it is expected to be issued at the end of 2026 or the beginning of 2027 due to the long evaluation cycle.Is it acceptable for us to submit our sterilizers with other EU CE certification and supplement the EU MDR certificates after they are available later? Answer: Bidders shall comply with the certification requirements specified in the solicitation documents. Where a product is classified as a Medical Device under the applicable regulatory framework, the required Medical Device certification shall be submitted as part of the bid. Post-submission of mandatory certifications will not be consideredQuestion: Please note that quantities are not mentioned anywhere in schedule of requirement or bid form. request you to please confirm the quantities of each lot.Answer: This solicitation is intended for the establishment of Long-Term Agreements (LTAs). The quantities indicated in the Price Form are estimated quantities provided solely for evaluation purposes and do not constitute any commitment by UNOPS to purchase a minimum quantity. Actual orders will be placed on an as-needed basis during the validity period of the LTA.Question : Is this tender only for manufacturers or can it also be for distributors of the products?Answer: The solicitation is open to both manufacturers and authorized distributors. Bidders shall comply with all qualification and technical requirements specified in the solicitation documents. Bidders that are not the manufacturer of the offered products shall submit a valid Manufacturer's Authorization Form in accordance with the requirements of the solicitation.Question : Item 27: Ultrapure water treatment equipment, Type I; Item 28: Purified water treatment equipment, Type II; and Item 29: Water treatment equipment, Type I & Type II — what types of laboratories are these three types of water treatment equipment respectively used in? Please specify the laboratory application scenarios for each of the three types of equipment.Answer: The intended laboratory applications may vary depending on the end-user requirements. In general: (i) Type I ultrapure water systems are commonly used for highly sensitive analytical applications such as molecular biology, cell culture, HPLC, ICP-MS, and other critical laboratory procedures; (ii) Type II purified water systems are generally used for routine laboratory applications, reagent preparation, media preparation, and as feed water for Type I systems; and (iii) Combined Type I & Type II systems are intended to provide both grades of water for laboratories requiring multiple water quality levels. Bidders shall offer products that meet the technical specifications stated in the solicitation documents. 

New amendment added #1: Amendment to Qualification Criteria under the Criteria TabRevision to Qualification Criteria No 3.3 shall read as follows:The BIDDER shall hold a valid ISO 9001:2015 Quality Management System certificate. Where the BIDDER is the manufacturer, the ISO 9001:2015 Quality Management System certificate shall be issued by an accredited certification body recognized under the International Accreditation Forum (IAF)